180 Life Sciences Corp (ATNF)
3.45
-0.29
(-7.75%)
USD |
NASDAQ |
Nov 04, 16:00
3.45
0.00 (0.00%)
After-Hours: 20:00
180 Life Sciences Cash from Operations (Quarterly): 0.7272M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.7272M |
| March 31, 2024 | -1.033M |
| December 31, 2023 | -2.16M |
| September 30, 2023 | -1.776M |
| June 30, 2023 | -3.117M |
| March 31, 2023 | -3.870M |
| December 31, 2022 | -2.927M |
| September 30, 2022 | -3.596M |
| June 30, 2022 | -3.532M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.073M |
| December 31, 2021 | -5.028M |
| September 30, 2021 | -4.003M |
| June 30, 2021 | -4.011M |
| March 31, 2021 | -6.33M |
| December 31, 2020 | -3.216M |
| September 30, 2020 | -0.054M |
| June 30, 2020 | -0.1926M |
| March 31, 2020 | -0.409M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.33M
Minimum
Mar 2021
0.7272M
Maximum
Jun 2024
-2.589M
Average
-3.022M
Median
Cash from Operations (Quarterly) Benchmarks
| Seelos Therapeutics Inc | -0.972M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.2649M |
| Free Cash Flow | -4.242M |
| Free Cash Flow Per Share (Quarterly) | 0.7911 |
| Free Cash Flow Yield | -195.9% |